Related Experiment Video
Updated: Feb 5, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
A comprehensive evaluation of Hippo pathway silencing in sarcomas
Nicole M Merritt1, Colleen A Fullenkamp1, Sarah L Hall1
1Department of Pathology, University of Iowa, Iowa City, IA, USA.
Abstract:
TAZ and YAP are transcriptional coactivators negatively regulated by the Hippo pathway that have emerged as key oncoproteins in several cancers including sarcomas. We hypothesized that loss of expression of the Hippo kinases might be a mechanism of activating TAZ and YAP. By immunohistochemistry, TAZ/YAP activated clinical sarcoma samples demonstrated loss of MST1 (47%), MST2 (26%), LATS1 (19%), and LATS2 (27%). Western blot similarly demonstrated loss of MST1 (58%), MST2 (25%), and LATS2 (17%). Treatment with MG132 demonstrated an accumulation of MST2 in 25% of sarcoma cell lines, indicating that proteosomal degradation regulates MST2 expression. qRT-PCR in sarcoma cell lines demonstrated loss of expression of the Hippo kinases at the RNA level, most pronounced in MST1 (42%) and MST2 (25%). 5-azacytidine treatment in sarcoma cell lines modestly reversed expression of predominantly MST1 (8%) and MST2 (17%), indicating CpG island hypermethylation can silence expression of MST1 and MST2. Trichostatin A treatment reversed expression of MST1 (58%) and MST2 (67%), indicating histone deacetylation also plays a role in silencing expression of MST1 and MST2. Loss of expression of the Hippo kinases is frequent in sarcomas and is due to a variety of mechanisms including regulation at the post-translational level and epigenetic silencing.
Insights
Loss of Hippo kinases (MST1/2, LATS1/2) is frequent in sarcomas, activating oncoproteins TAZ/YAP. Mechanisms include post-translational degradation and epigenetic silencing via hypermethylation and histone deacetylation.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- TAZ and YAP are key oncoproteins in various cancers, including sarcomas.
- The Hippo pathway negatively regulates TAZ and YAP activity.
- Loss of Hippo kinase expression is a potential mechanism for TAZ/YAP activation.
Purpose of the Study:
- To investigate the frequency and mechanisms of Hippo kinase (MST1, MST2, LATS1, LATS2) loss of expression in sarcomas.
- To determine if TAZ/YAP activation in clinical sarcoma samples correlates with Hippo kinase expression levels.
Main Methods:
- Immunohistochemistry on clinical sarcoma samples.
- Western blot analysis of sarcoma cell lines.
- Quantitative reverse transcription PCR (qRT-PCR) to assess gene expression.
- Treatment with MG132 (proteasome inhibitor), 5-azacytidine (demethylating agent), and Trichostatin A (histone deacetylase inhibitor).
Main Results:
- Loss of Hippo kinases was observed in TAZ/YAP-activated clinical sarcoma samples (MST1: 47%, MST2: 26%, LATS1: 19%, LATS2: 27%).
- Western blot confirmed loss of MST1 (58%), MST2 (25%), and LATS2 (17%).
- MG132 treatment caused MST2 accumulation, indicating proteasomal degradation.
- qRT-PCR showed reduced expression of MST1 (42%) and MST2 (25%) at the RNA level.
- 5-azacytidine and Trichostatin A treatments partially restored MST1/MST2 expression, suggesting epigenetic silencing (CpG hypermethylation and histone deacetylation).
Conclusions:
- Loss of Hippo kinase expression is a frequent event in sarcomas.
- This loss contributes to TAZ/YAP activation, promoting oncogenesis.
- Multiple mechanisms, including post-translational regulation and epigenetic silencing, underlie Hippo kinase loss in sarcomas.
More Related Videos
08:26A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
Published on: April 12, 2018
06:49Using Eye Movements to Evaluate the Cognitive Processes Involved in Text Comprehension
Published on: January 10, 2014
Related Concept Videos
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Other Glycolytic Pathways
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
Respiration Pathways